Prosthetic Heart Valve Market Size to Achieve USD 23.16 Billion by 2032

The global prosthetic heart valve market revenue is estimated to exhibit a strong CAGR of 11.0% over the forecast period and exceed a market valuation of US$ 23.16 Billion by 2032, from US$ 7.35 Billion in 2022.

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Get a Sample PDF Report :

Prosthetic Heart Valve Market Key Segments Covered:

By Product Type

  • Mechanical Heart Valves
  • Mechanical Aortic Valve
  • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
  • Tissue Aortic Valve
  • Tissue Mitral Valve
  • Transcatheter Heart Valves
  • Transcatheter Aortic Valve
  • Transcatheter Mitral Valve

By End User

  • Hospitals
  • Ambulatory Surgery Centres

By Region

  • North America
  • Latin America Excluding Brazil
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Middle East & Africa (MEA)

Talk to Analyst:

Segmental Forecast:

  • The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
  • The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional Market Overview:

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.

Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Buy this Report Now :

Competition Analysis:

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are –

  • Edwards Lifesciences Corporation
  • St. Jude Medical, Inc.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.

Leading market players are focusing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include: product approvals and commercialization, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

Explore Top Reports from Healthcare Market:

Radial Compression Devices Market : The global Radial Compression Devices Market value at US$ 232.5 Mn in 2022 and is expected to reach US$ 504.0 Mn by 2031.

Lab Automation Market : The lab automation market was valued at US$ 1.73 Billion in 2021. With rising adoption of lab automation across various end use verticals, the overall market is likely to grow at a CAGR of 9.6% through 2027, reaching US$ 3 Billion by 2027.

Liquid Biopsy Market : As per a recent market analysis by ESOMAR-certified firm Future Market Insights (FMI), the global Liquid Biopsy Market value is pegged to reach US$ 1,026 Mn in 2021. Rising at 13.49% CAGR the market is expected to total US$ 3,637 Mn by 2031.

Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: